Company Filing History:
Years Active: 2017-2018
Title: Innovations by Inventor Chien-Hsin Chang
Introduction
Chien-Hsin Chang is a notable inventor based in Taipei, Taiwan, recognized for his contributions to the field of pharmaceutical innovations. With two patents to his name, his work primarily focuses on developing peptide compounds that play a crucial role in inhibiting platelet aggregation, which is vital for preventing thrombogenic diseases.
Latest Patents
Chien-Hsin Chang's latest patents include cutting-edge research on peptide compounds for the inhibition of platelet aggregation. These inventions are particularly significant as they involve the creation of pentapeptides and hexapeptides derived from snake venom C-type lectin-like proteins (CLPs) fragments. This innovative approach not only inhibits platelet aggregation but also shows antithrombotic activity without the associated risk of hemorrhage. Such advancements indicate the potential of these compounds in both the prevention and treatment of thrombogenic diseases.
Career Highlights
Chien-Hsin Chang has made significant strides in pharmaceutical research while working at National Taiwan University. His academic role allows him to explore various applications and implications of his inventions, solidifying his reputation as a leading figure in his field. The patents he has secured underscore his commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Chien-Hsin Chang has collaborated with several distinguished colleagues, including Tur-Fu Huang and Ching-Hu Chung. These partnerships have fostered an environment of innovation and creativity, contributing to the successful development of his patented inventions. Collaboration among researchers is often essential in the scientific community, and Chang's work illustrates the impact of teamwork on groundbreaking discoveries.
Conclusion
Chien-Hsin Chang's contributions to the field of pharmaceutical sciences through his innovative peptide compounds demonstrate the vital intersection of research and practical application in medicine. As he continues to advance our understanding of thrombogenic diseases, his work will likely pave the way for new therapeutic strategies that enhance health outcomes for patients worldwide.